RDEA 594 and allopurinol in patients with gout.

Trial Profile

RDEA 594 and allopurinol in patients with gout.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Nov 2010

At a glance

  • Drugs Allopurinol; Lesinurad
  • Indications Gout
  • Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 08 Nov 2010 Results reported in an Ardea Biosciences media release.
    • 21 Jun 2010 New trial record
    • 19 Jun 2010 Interim results presented at the Annual European Congress of Rheumatology in June 2010, according to an Ardea Biosciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top